Cure My Disease

Don't miss your cure!

 Log in / Sign up

Smart radiation tailored to each tumor could extend lung cancer survival

NCT ID NCT07164885

Recruiting now Disease control Sponsor: Capital Medical University Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 30 times

Summary

This study tests a new approach to radiation therapy for people with stage III lung cancer that cannot be removed by surgery. The treatment uses a special technology called RAPART to personalize the radiation dose based on how sensitive each person's tumor is to radiation. The goal is to see if this tailored approach helps people live longer and keeps the cancer from growing, compared to standard radiation. About 911 adults will take part in this research.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED NON SMALL CELL LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Hong Kong Shenzhen Hospital

    RECRUITING

    Shenzhen, Guangdong, 518000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

LOCALLY ADVANCED NON SMALL CELL LUNG CANCER